Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1985 1
1986 2
1987 1
1988 3
1989 1
1991 1
1992 1
1993 2
1995 2
1996 1
1997 1
1999 2
2000 2
2001 3
2003 2
2005 2
2006 1
2007 1
2008 1
2009 1
2010 1
2011 2
2012 1
2013 2
2015 4
2016 4
2017 1
2018 2
2019 2
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells.
Ghislanzoni S, Sarcinelli GM, Bresci A, Manetti F, Polli D, Tomassetti A, Radice MT, Bongarzone I. Ghislanzoni S, et al. Among authors: tomassetti a. Int J Biochem Cell Biol. 2023 Jun;159:106419. doi: 10.1016/j.biocel.2023.106419. Epub 2023 Apr 21. Int J Biochem Cell Biol. 2023. PMID: 37086817 Free PMC article.
Axl in ovarian cancer: a step forward for clinical breakthrough?
Sensi M, Canevari S, Tomassetti A. Sensi M, et al. Among authors: tomassetti a. Oncotarget. 2016 Dec 6;7(49):80105-80106. doi: 10.18632/oncotarget.13457. Oncotarget. 2016. PMID: 27876698 Free PMC article. No abstract available.
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
Forlani L, De Cecco L, Simeon V, Paolini B, Bagnoli M, Cecere SC, Spina A, Citeroni E, Bignotti E, Lorusso D, Arenare L, Russo D, De Angelis C, Ardighieri L, Scognamiglio G, Del Sesto M, Tognon G, Califano D, Schettino C, Chiodini P, Perrone F, Mezzanzanica D, Pignata S, Tomassetti A. Forlani L, et al. Among authors: tomassetti a. J Exp Clin Cancer Res. 2023 Apr 11;42(1):83. doi: 10.1186/s13046-023-02651-y. J Exp Clin Cancer Res. 2023. PMID: 37041632 Free PMC article.
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
Rizzo A, Satta A, Garrone G, Cavalleri A, Napoli A, Raspagliesi F, Figini M, De Cecco L, Iorio E, Tomassetti A, Mezzanzanica D, Bagnoli M. Rizzo A, et al. Among authors: tomassetti a. J Exp Clin Cancer Res. 2021 Jan 4;40(1):5. doi: 10.1186/s13046-020-01794-6. J Exp Clin Cancer Res. 2021. PMID: 33390181 Free PMC article.
58 results